Allianz Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-94,805
| Closed | -$2.27M | – | 2533 |
|
|
2021
Q1 | $2.27M | Sell |
94,805
-194,661
| -67% | -$3.62M | ﹤0.01% | 1358 |
|
|
2020
Q4 | $4.23M | Buy |
289,466
+33,648
| +13% | +$446K | ﹤0.01% | 1096 |
|
|
2020
Q3 | $3.63M | Buy |
255,818
+137,341
| +116% | +$2.1M | ﹤0.01% | 1080 |
|
|
2020
Q2 | $1.74M | Buy |
+118,477
| New | +$1.2M | ﹤0.01% | 1661 |
|
|
2018
Q1 | – | Sell |
-273,636
| Closed | -$1.14M | – | 2786 |
|
|
2017
Q4 | $1.14M | Sell |
273,636
-3,299
| -1% | -$19.9K | ﹤0.01% | 2201 |
|
|
2017
Q3 | $2.67M | Buy |
276,935
+6,469
| +2% | +$67.2K | ﹤0.01% | 1896 |
|
|
2017
Q2 | $3.2M | Buy |
270,466
+18,842
| +7% | +$241K | ﹤0.01% | 1804 |
|
|
2017
Q1 | $3.23M | Buy |
251,624
+7,074
| +3% | +$85.1K | ﹤0.01% | 1817 |
|
|
2016
Q4 | $2.99M | Sell |
244,550
-38,506
| -14% | -$457K | ﹤0.01% | 1823 |
|
|
2016
Q3 | $3.34M | Buy |
+283,056
| New | +$2.73M | ﹤0.01% | 1786 |
|
|
2013
Q3 | – | Sell |
-224,799
| Closed | -$2.33M | – | 1857 |
|
|
2013
Q2 | $2.33M | Buy |
+224,799
| New | +$3.1M | ﹤0.01% | 1160 |
|
Allianz Asset Management's GNMK Position: Q2 2021 in Review
Allianz Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 94,805 shares — an estimated $2.27M sold.
Allianz Asset Management first reported a position in GNMK in Q2 2013 and held it in 11 quarters. The position peaked at $4.23M in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Allianz Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Allianz Asset Management sold 94,805 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $2.27M.
- Allianz Asset Management first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 11 quarters.
- Allianz Asset Management's GenMark Diagnostics, Inc position peaked at $4.23M in Q4 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Allianz Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.